{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:38:00Z","timestamp":1761165480126,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s11605-019-04104-4","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T15:12:23Z","timestamp":1548947543000},"page":"2232-2238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Role of Adjuvant Chemotherapy in Resected T2N0 Gall Bladder Cancer"],"prefix":"10.1016","volume":"23","author":[{"given":"Abhay K.","family":"Kattepur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8489-6825","authenticated-orcid":false,"given":"Shraddha","family":"Patkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahesh","family":"Goel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anant","family":"Ramaswamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Ostwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s11605-019-04104-4_bb0010","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/SLA.0000000000002385","article-title":"Surgical management of gall bladder cancer: simple versus extended cholecystectomy and the role of adjuvant therapy","volume":"266","author":"Kasumova","year":"2017","journal-title":"Ann Surg"},{"key":"10.1007\/s11605-019-04104-4_bb0015","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1186\/s12885-015-1498-0","article-title":"Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gall bladder carcinoma (ACTICCA-1 trial): A randomised, multidisciplinary, multinational phase III trial","volume":"15","author":"Stein","year":"2015","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1007\/s11605-019-04104-4_bb0020","first-page":"XCO1","article-title":"Impact of adjuvant therapy on survival in curatively resected gall bladder carcinoma","volume":"9","author":"Choudhary","year":"2015","journal-title":"Journal of Clinical and Diagnostic Research"},{"issue":"9","key":"10.1007\/s11605-019-04104-4_bb0025","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1007\/s11605-012-1935-1","article-title":"Neither Neoadjuvant nor Adjuvant Therapy Increases Survival After Biliary Tract Cancer Resection with Wide Negative Margins","volume":"16","author":"Glazer","year":"2012","journal-title":"Journal of Gastrointestinal Surgery"},{"key":"10.1007\/s11605-019-04104-4_bb0030","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1080\/13651820802029427","article-title":"The role of chemotherapy in biliary tract carcinoma","volume":"10","author":"Verslype","year":"2008","journal-title":"HPB"},{"key":"10.1007\/s11605-019-04104-4_bb0035","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S1072-7515(01)00814-6","article-title":"Surgical treatment of patients with T2 gall bladder carcinoma invading the subserosal layer","volume":"192","author":"Chijiiwa","year":"2001","journal-title":"J Am Coll Surg."},{"key":"10.1007\/s11605-019-04104-4_bb0040","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/hpb.12444","article-title":"Gall bladder Cancer: expert consensus statement","volume":"17","author":"Aloia","year":"2015","journal-title":"HPB"},{"issue":"4","key":"10.1007\/s11605-019-04104-4_bb0045","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.4143\/crt.2015.502","article-title":"Is there a role for adjuvant therapy in R0 resected gall bladder cancer?: a propensity score-,matched analysis","volume":"48","author":"Go","year":"2016","journal-title":"Can Res Treat"},{"key":"10.1007\/s11605-019-04104-4_bb0050","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1200\/JCO.2010.33.8020","article-title":"Normogram for predicting the benefit of adjuvant chemoradiotherapy for resected gall bladder cancer","volume":"29","author":"Wang","year":"2011","journal-title":"J Clin Oncol."},{"key":"10.1007\/s11605-019-04104-4_bb0055","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000322914","article-title":"Outcome of adjuvant therapy in gall bladder cancer","volume":"79","author":"Park","year":"2010","journal-title":"Oncology"},{"key":"10.1007\/s11605-019-04104-4_bb0060","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/COC.0b013e31829e19fb","article-title":"Outcome of adjuvant therapy in biliary tract cancers","volume":"38","author":"McNamara","year":"2015","journal-title":"Am J Clin Oncol."},{"key":"10.1007\/s11605-019-04104-4_bb0065","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12885-017-3967-0","article-title":"Adjuvant treatment in resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single centre phase II study","volume":"18","author":"Siebenhuner","year":"2018","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1007\/s11605-019-04104-4_bb0070","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4174\/jkss.2012.83.4.227","article-title":"Prognostic factors for gall bladder cancer in the laparoscopic era","volume":"83","author":"Lee","year":"2012","journal-title":"J Korean Surg. Soc."},{"issue":"5","key":"10.1007\/s11605-019-04104-4_bb0075","first-page":"e298","article-title":"Role of adjuvant chemotherapy in T2N0M0 periampullary cancers","volume":"13","author":"Ostwal","year":"2016","journal-title":"Asia-Pacific Journal of Clinical Oncology"},{"key":"10.1007\/s11605-019-04104-4_bb0080","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1440-1746.2011.07048.x","article-title":"Gall bladder cancer: can newer insights improve outcome?","volume":"27","author":"Dutta","year":"2012","journal-title":"Journal of Gastroeneterology and Hepatology"},{"issue":"16","key":"10.1007\/s11605-019-04104-4_bb0085","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1200\/JCO.2011.40.5381","article-title":"Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis","volume":"30","author":"Horgan","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1007\/s11605-019-04104-4_bb0090","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1186\/s12885-015-1617-y","article-title":"Adjuvant therapy in the treatment of gall bladder cancer: a meta-analysis","volume":"15","author":"Ma","year":"2015","journal-title":"BMC Cancer"},{"issue":"4_suppl","key":"10.1007\/s11605-019-04104-4_bb0095","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1200\/JCO.2017.35.4_suppl.225","article-title":"Gemox versus surveillance following surgery of localized biliary tract cancer: Results of the PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trial","volume":"35","author":"Edeline","year":"2017","journal-title":"Journal of Clinical Oncology"},{"issue":"supl;abstr 4125","key":"10.1007\/s11605-019-04104-4_bb0100","first-page":"4125","article-title":"BILCAP. A randomised clinical trial evaluating adjuvant chemotherapy with capecitabine compared to expectant treatment alone following curative surgery for biliary tract cancer","volume":"29","author":"Primrose","year":"2011","journal-title":"J ClinOncol"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11605-019-04104-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-019-04104-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23028949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23028949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-019-04104-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T19:55:11Z","timestamp":1761076511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X23028949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1091255X23028949"],"URL":"https:\/\/doi.org\/10.1007\/s11605-019-04104-4","relation":{},"ISSN":["1091-255X"],"issn-type":[{"type":"print","value":"1091-255X"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Adjuvant Chemotherapy in Resected T2N0 Gall Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s11605-019-04104-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 Society for Surgery of the Alimentary Tract. Published by ELSEVIER INC. All rights reserved. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}